Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
Multiple Myeloma (MM) is a hematologic malignancy characterized by clonal plasma cell development, leading to serious complications. Despite traditional treatments, MM remains incurable, necessitating innovative therapeutic approaches. Chimeric Antigen Receptor (CAR) T-cell therapy and Bispecific T-...
Saved in:
Main Authors: | Rahul Navab, Pragyat Futela, Verkha Kumari, Jayesh Valecha, Ramansh Bandhu Gupta, Rohit Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2025-01-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_50407_ad2eaf591bada72e1e5d479cee299d69.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
by: Ugo Testa, et al.
Published: (2024-10-01) -
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
by: Joseph Sassine, et al.
Published: (2025-01-01) -
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
by: Ziping Li, et al.
Published: (2025-01-01) -
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach
by: Punchita Rujirachaivej, et al.
Published: (2025-01-01) -
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
by: Juanjuan Zhao, et al.
Published: (2025-01-01)